SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 8th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of August _, 2023, by and between Innovation1 Biotech Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT NOTIS GLOBAL, INC.GridIron BioNutrients, Inc. • February 5th, 2020 • Pharmaceutical preparations • Nevada
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, GridIron BioNutrients, Inc., or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 24, 2020 (the “Initial Exercise Date”), and on or prior to the close of business on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Notis Global, Inc., a Nevada corporation (the “Company”), up to one hundred million (100,000,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being granted in connection with that certain 12.5% Original Issue Discount Promissory Note with the issue date of January 24, 2020, of the Company’s subsidiary
ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE PROMISSORY NOTEInnovation1 Biotech Inc. • December 13th, 2023 • Pharmaceutical preparations
THIS ORIGINAL ISSUE DISCOUNT SECURED CONVERTIBLE PROMISSORY NOTE is duly authorized and validly issued at an original issue discount by Innovation1 Biotech Inc., a Nevada corporation (the “Company”) (the “Note”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 13th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of December 6, 2023, by and between Innovation1 Biotech Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 10th, 2017 • My Cloudz, Inc. • Services-computer processing & data preparation • Nevada
This Indemnification Agreement (the “Agreement”) is made as of October 9, 2017, by and between My Cloudz, Inc., a Nevada corporation (the “Company”), and Timothy Orr (the “Indemnitee”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 24th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of April 13, 2023, by and between Innovation1 Biotech Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
FORM OF SECURITIES PURCHASE AGREEMENT]Securities Purchase Agreement • August 16th, 2018 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), is entered into as of July 30, 2018 (the “Execution Date”), by and among Gridiron BioNutrients, Inc., a Nevada corporation, with headquarters located at 1119 West 1st Ave., Ste. G, Spokane, Washington 99021 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITY AGREEMENTSecurity Agreement • April 24th, 2023 • Innovation1 Biotech Inc. • Pharmaceutical preparations
THIS SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) dated as of November 29, 2022, between Innovation1 Biotech Inc., a Nevada corporation (the “Company”) (the Company and each other Person who becomes a party to this Agreement by execution of a joinder in the form of Exhibit A attached hereto, which shall include all wholly-owned or majority-owned subsidiaries of the Company acquired after the date hereof for so long as this Agreement remains in effect, are hereinafter sometimes referred to individually as a “Debtor” and, collectively, as the “Debtors”) and Cavalry Fund I LP, a limited partnership organized and existing under the laws of the State of Delaware, in its capacity as a purchaser and as Collateral Agent for the benefit of itself and each of the other purchasers (together with their respective successors and assigns, each a “Secured Party” and collectively, the “Secured Parties”) who execute this Agreement.
FORM OF REGISTRATION RIGHTS AGREEMENT]Registration Rights Agreement • August 16th, 2018 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of July 30, 2018 (the “Execution Date”), is entered into by and among GRIDIRON BIONUTRIENTS, INC., a Nevada corporation (the “Company”), and the undersigned buyers (each, a “Buyer” and collectively, the “Buyers”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Securities Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANT Innovation1 Biotech, Inc.Innovation1 Biotech Inc. • December 13th, 2023 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 6, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Innovation1 Biotech, Inc., a Nevada corporation (the “Company”), up to 735,294 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COLLABORATION AGREEMENTCollaboration Agreement • December 15th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
This Collaboration Agreement (this “Agreement”) is made as of January 24, 2020, by and between Notis Global, Inc. (“NGBL”), and GridIron BioNutrients, Inc. (“GMVP”).
MASTER SERVICES AGREEMENTMaster Services Agreement • April 21st, 2022 • Innovation1 Biotech Inc. • Pharmaceutical preparations • New York
This MASTER SERVICES AGREEMENT (“Agreement”) is entered into as of April 7, 2022 (the “Effective Date”) by and between Salzman Group Ltd. with an address at 18 Hagat St., Kazrin 1290005, Israel together with its affiliates, Salzman Group, Inc., Salzman Investments Ltd., Salzman Group Pty. Ltd., Quitsa Pharmaceuticals Ltd., and Herring Creek Pharmaceuticals, Inc. (collectively “Service Provider”) and Innovation1 Biotech Inc., a Nevada corporation, with offices at 40 Wall Street, Suite 2701, New York, New York 10005, USA (“Company”). Each of Service Provider and Company shall be referred to hereunder as a “Party”, and collectively as the “Parties”.
AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 8th, 2021 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of November 5, 2021, by and between GRIDIRON BIONUTRIENTS, INC., a Nevada corporation (“Purchaser”), ST BIOSCIENCES, LTD., a company organized under the laws of England and Wales (“Seller”) and Jason Frankovich, an individual residing in the State of New York (“Frankovich”). Certain capitalized terms used but not otherwise defined in this Agreement are defined as set forth in Exhibit A.
SUPPLY AGREEMENTSupply Agreement • February 5th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Colorado
This Agreement (“the Agreement”), is made by and between EWSD 1, LLC, d/b/a/ SHI FARMS (“Shi Farms”), a Delaware limited liability company and Gridiron BioNutrients, Inc, a Nevada Corporation (“Gridiron”) , each individually “a Party,” and collectively, “the Parties.”
EXCHANGE AGREEMENTExchange Agreement • April 12th, 2021 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • New York
THIS EXCHANGE AGREEMENT (the “Agreement”) is made as of the 9th day of April, 2021 by and between Gridiron Nutrients, Inc., a Nevada corporation (the “Company”), and the holder signatory hereto (the “Holder”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 5th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
THIS AGREEMENT is made and entered into this 24th day of January 2020, by and between Notis Global, Inc. (“Seller”/”NGBL”) a Nevada corporation and Gridiron BioNutrients, Inc. a Nevada corporation (“Purchaser”/”GMVP”) with regard certain capital stock of NGBL.
ENDORSEMENT AGREEMENTEndorsement Agreement • December 6th, 2017 • My Cloudz, Inc. • Pharmaceutical preparations • California
This Endorsement Agreement (“Agreement”) made October 30, 2017, between National Football League Alumni – Northern California Chapter (“NFLA-NC”), a charitable corporation organized under the laws of California, having its principal office at 1311 Madison Avenue, Redwood CA 94061; National Football League Alumni, Inc. (“NFLA”), a charitable corporation organized under the laws of Florida, having its principal office at 8000 Midlantic Drive, 130 S., Mount Laurel, NJ. 08054 and Food For Athletes, Inc. a corporation organized under the laws of California / Gridiron BioNutrients™, a corporation organized under the laws of Nevada having their principal office(s) at 1119 West 1st Ave., STE G, Spokane, WA 99201 (collectively the “Company”).
ENDORSEMENT AGREEMENT ADDENDUM IEndorsement Agreement Addendum I • December 6th, 2017 • My Cloudz, Inc. • Pharmaceutical preparations
The NFLA, NFLA-NC and the Company (collectively the “Parties”) agree that this Addendum I shall be affixed and be enforceable under the terms of the Endorsement Agreement executed by the Parties on October 30, 2017.
SUPPLY AGREEMENTSupply Agreement • December 15th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Colorado
This Agreement (“the Agreement”), is made by and between EWSD 1, LLC, d/b/a/ SHI FARMS (“Shi Farms”), a Delaware limited liability company and Gridiron BioNutrients, Inc, a Nevada Corporation (“Gridiron”) , each individually “a Party,” and collectively, “the Parties.”
STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 5th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
THIS AGREEMENT is made and entered into this 28th day of January 2020, by and between Gridiron BioNutrients, Inc. (“Purchaser”) and Grays Peak Ventures (“Seller”) with regard certain capital stock of Gridiron BioNutrients, Inc. a Nevada corporation (“Corporation”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 15th, 2020 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), is entered into as of July 30, , 2018 (the “Execution Date”), by and among Gridiron BioNutrients, Inc., a Nevada corporation, with headquarters located at 1119 West 1st Ave., Ste. G, Spokane, Washington 99021 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
Description of Verbal Agreement by and between My Cloudz, Inc. and Darren LongVerbal Agreement • February 2nd, 2018 • My Cloudz, Inc. • Pharmaceutical preparations
My Cloudz, Inc., a Nevada corporation (the “Company”) and Darren Long are parties to an oral contract dated October 9, 2017. Mr. Long, the Chief Executive Officer and Chairman of the Board of Directors of the Company, has provided the Gridiron MVP™ formulations (the “Formulations”) to the Company at no charge to the Company. The Company has the exclusive right to develop CBD products with the Formulations. However, the Company is limited to developing only CBD products with the Formulations and as such does not have any rights to develop products that do not contain CBD with this formulation. This grant was granted by Mr. Long in connection with Mr. Long receiving 32,500,000 shares of common stock of the My Cloudz, Inc., a Nevada corporation, pursuant to that certain Share Exchange Agreement, by and among the Company, GridIron BioNutrients, Inc., a Nevada corporation (“GridIron BioNutrients”), and the holders of common stock of GridIron BioNutrients.
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2022 • Innovation1 Biotech Inc. • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of April 14, 2022 (the “Effective Date”), by and between Dr. Andrew Salzman (the “Employee”) and Innovation1 Biotech Inc., a Nevada corporation (the “Company”) (collectively referred to herein as the “Parties”).
SERIES B-1 PURCHASE AGREEMENTSeries B-1 Purchase Agreement • November 29th, 2021 • GridIron BioNutrients, Inc. • Pharmaceutical preparations • Nevada
THIS SERIES B-1 PURCHASE AGREEMENT (the “Agreement”) is made as of the 24th day of November 2021 by and between Gridiron Nutrients, Inc., a Nevada corporation (the “Company”), and the Purchaser signatory hereto (the “Purchaser”).
